Bellerophon Therapeutics, Inc.: cashflow_investing

Value{"amount": 0, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"}
Period2019-01-01 – 2019-06-30
Statuscurrent
EntityBellerophon Therapeutics, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001600132-19-000105 · Open the official SEC filing →
Retrieved: 2026-08-19T16:22:44.668338+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001600132/cashflow-investing/2019-06-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/9ef5ad98-68b1-461e-97f3-ea48ced435dc

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies